BioWorld MedTech

Aug. 20, 2014

Financings: HQC closes debut fund at $110M to invest in healthcare sectors

HealthQuest Capital (HQC; Menlo Park, California), a new fund sponsored by Sofinnova Ventures, reported the closing of its debut fund at the hard cap of $110 million and in excess of the initial fund target of $50 million. Read More

Nasal brush test could safely diagnose early prion infection in patients

Medtronic sees profit decline, improvement in sales for 1Q14

Protectionist policy being pursued: China to promote domestic devices among its top hospital facilities

HIT Bits: Firm shows how crucial EMRs are in the big data revolution

Agreements/contracts: Cytori and BARDA continue cell development for thermal burns

Daily M&A: LeMaitre Vascular acquires Xenotis for $7.7 million

Product briefs

People in Places

MDD's Oncology Extra

Today's news in brief

BioWorld

BioWorld briefs for April 4, 2025.

Today's news in brief

BioWorld MedTech

BioWorld MedTech briefs for April 4, 2025.

Caution tape displaying US flag, tariffs

Biopharma exempt from US reciprocal tariffs, but not untouched

BioWorld

At first glance, it appears that biopharmaceuticals dodged the latest U.S. tariff bullet; med-tech, not so much. According to the executive order President Donald...

3D rendering of glucagon-like peptide 1 (GLP-1)

ADPD 2025: Unlocking GLP-1's potential in neurodegeneration

BioWorld

At the recently launched Alzheimer’s & Parkinson’s Diseases Conference held in Vienna, Lotte Bjerre Knudsen from Novo Nordisk A/S, who has extensive experience in...

Immune checkpoint inhibitors illustration of PD-1, CTLA-4 and PD-L1.

Checkpoint inhibitor journey traces Chinese firms’ path to global revenue

BioWorld

Chinese pharmaceutical companies are making significant inroads into the global oncology market, particularly with the development and approval of immune...